Global Bare Metal Stents Market 2017-2021

Overview of the global bare metal stent market

Market research analysts at Technavio predict that the global bare metal stent market will grow steadily at a CAGR of over 1% by 2021. This market research analysis identifies the presence of favorable reimbursement scenarios as one of the primary growth factors for this market. Insurance regulatory firms are making the reimbursement policies for medical devices well structured. The reimbursement policies for stents have seen an increase in costs covered compared with that of the previous years. This change in reimbursement policies will drive the preference towards bare metal stents in the coming years, which will subsequently drive market growth.

The rise in number of cath labs is one of the latest trends that will gain traction in the bare metal stent market in the coming years. Cath labs can successfully handle complex coronary and valvular cases safely. With the rise in number of these cases, the success rates of the procedures performed in cath labs have also increased. Apart from the clinical success, the cath labs are also involved in various single center and multicenter trials in coronary interventions.

Competitive landscape and key vendors

The bare metal stent market is concentrated and the three major players account for most of the shares. There other players are confined to a region and have a limited product portfolio. To gain a competitive edge over their competitors, the vendors have the need to develop new and innovative products.

The leading vendors in the market are -

• Abbott
• Boston Scientific
• Medtronic

The other prominent vendors in the market include Alvimedica, B. Braun Medical, Balton, Biosensors International, BIOTRONIK, ENDOCOR, Meril Life Sciences, MicroPort Scientific, ORBUSNEICH, RONTIS, and Terumo Medical.

Segmentation by end-user and analysis of the bare metal stent market

• ASCs
• Hospitals
• Physicians' offices

ASCs successfully perform coronary surgeries that are minimally invasive. Market research analysts estimates that the ASCs segment accounted for the major shares of this marketspace during 2016. The availability of a limited number of beds at hospitals that makes it difficult to handle the large number of coronary interventions will promote outpatient practices.

Geographical segmentation and analysis of the bare metal stent market

• Americas
• APAC
• EMEA

This market study estimates that in terms of geographic regions, APAC will be the major revenue contributor to the market by 2021. The bare metal stent is priced almost three times lower than the drug-eluting stent (DES). Initiatives from the government of India such as imposing a price cap on the bare metal stent will help in augmenting the market’s growth prospects in this region.

Key questions answered in the report include

• What will the market size and the growth rate be in 2021?
• What are the key factors driving the global bare metal stent market?
• What are the key market trends impacting the growth of the global bare metal stent market?
• What are the challenges to market growth?
• Who are the key vendors in the global bare metal stent market?
• What are the market opportunities and threats faced by the vendors in the global bare metal stent market?
• What are the trending factors influencing the market shares of the Americas, APAC, and EMEA?
• What are the key outcomes of the five forces analysis of the global bare metal stent market?

Technavio also offers customization on reports based on specific client requirement